Back to BlackRock, Inc. BlackRock, Inc.

KROSKROS
8 quarters

Position history for BlackRock, Inc.BlackRock, Inc.'s holdings in KEROS THERAPEUTICS INC

BlackRock, Inc. holds 2.8M shares of KROS (KEROS THERAPEUTICS INC), worth $29.9M as of 2026-Q2. The position was increased (+15.9% shares). KROS represents 0.0% of BlackRock, Inc.'s portfolio.

Current Value

$29.9M

Current Shares

2.8M

Total Value Change

-$123M

Total Shares Change

+161,609

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
2.8M
+15.9%
$29.9M0.0%$10.70
33
2026-Q1
Increased
2.4M
+5.3%
$26.6M0.0%$13.40
30
2025-Q4
Decreased
2.3M
-15.7%
$46.6M0.0%$20.27
0
2025-Q3
Decreased
2.7M
-0.6%
$43M0.0%$15.95
0
2025-Q2
Decreased
2.7M
-1.9%
$36.5M0.0%$13.49
0
2025-Q1
Increased
2.8M
+2.0%
$28.4M0.0%$10.79
29
2024-Q4
Increased
2.7M
+3.7%
$43.2M0.0%$15.83
30
2024-Q3
First report
2.6M
-
$152.9M0.0%$58.07
0

Other major holders of KROS: FMR LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used